Liven Pharma (KAR:LIVEN) EBIT : ₨ Mil (TTM As of . 20)

View and export this data going back to 2007. Start your Free Trial

What is Liven Pharma EBIT?

Liven Pharma's earnings before interest and taxes (EBIT) for the six months ended in . 20 was ₨0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Liven Pharma EBIT Historical Data

The historical data trend for Liven Pharma's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Liven Pharma EBIT Chart

Liven Pharma Annual Data

Trend

EBIT

Liven Pharma Semi-Annual Data

EBIT

Competitive Comparison of Liven Pharma's EBIT

For the Textile Manufacturing subindustry, Liven Pharma's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Liven Pharma's EV-to-EBIT Distribution in the Manufacturing - Apparel & Accessories Industry

For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Liven Pharma's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Liven Pharma's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Liven Pharma EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in . 20 was ₨ Mil.

Liven Pharma (KAR:LIVEN) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Liven Pharma's annualized ROC % for the quarter that ended in . 20 is calculated as:

	ROC % (Q: . 20 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: . 20 )	+	Invested Capital (Q: . 20 ))	/ count )
=	* ( 1 - % )	/	( (	+	)	/ )
=		/
=	%

where

Invested Capital

(Q: . 20 )

Total Assets

Accounts Payable & Accrued Expense

Excess Cash

Total Assets

Accounts Payable & Accrued Expense

( Cash, Cash Equivalents, Marketable Securities

max(0, Total Current Liabilities

Total Current Assets

Cash, Cash Equivalents, Marketable Securities

))

(

max(0,

))

Invested Capital

(Q: . 20 )

Total Assets

Accounts Payable & Accrued Expense

Excess Cash

Total Assets

Accounts Payable & Accrued Expense

( Cash, Cash Equivalents, Marketable Securities

max(0, Total Current Liabilities

Total Current Assets

Cash, Cash Equivalents, Marketable Securities

))

(

max(0,

))

Note: The Operating Income data used here is one times the annual (. 20) data.

2. Joel Greenblatt's definition of Return on Capital:

Liven Pharma's annualized ROC (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

	ROC (Joel Greenblatt) %		(Q: . 20 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: . 20		Q: . 20
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=		/	( ( ( + max(, 0))	+	( + max(, 0)) )	/	)
=		/	( (	+	)	/	)
=		/
=	%

where Working Capital is:

	Working Capital		(Q: . 20 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(	+		+	)	-	(	+		+	)
=

	Working Capital		(Q: . 20 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(	+		+	)	-	(	+		+	)
=

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (. 20) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Liven Pharma's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: . 20 )
	=		/	1045.912
	=	%

Liven Pharma EBIT Related Terms

Thank you for viewing the detailed overview of Liven Pharma's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Liven Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Manufacturing - Apparel & Accessories » Liven Pharma Ltd (KAR:LIVEN) » Definitions » EBIT

Traded in Other Exchanges

N/A

Address

I.I Chundrigar Road, 1st Floor, The Cotton Exchange Building, Karachi, SD, PAK, 75350

Website

http://www.landmarkspinning.com

Liven Pharma Ltd, formerly Landmark Spinning Industries Ltd is engaged in trading, manufacturing, and sale of yarn.

Liven Pharma Headlines

No Headlines